Paxlovid
Paxlovid is a medicine authorised by Swissmedic under authorisation number 68793. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 June 2022 and the authorisation is limited until 04 April 2029. ATC code J05AE30 places the medicine in the group Antivirals for systemic use.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Paxlovid, Filmtabletten | A | 15 June 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | J05AE30 | 08.03.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Paxlovid authorised in Switzerland?
Yes. Paxlovid is authorised by Swissmedic under authorisation number 68793, data as of 01 September 2026. The authorisation is limited until 04 April 2029.
Which dispensing category does Paxlovid have?
Paxlovid is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Paxlovid?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.